Is there a treatment for sarcopenia?

While there is no pharmacological treatment for sarcopenia, alternative interventions can help improve muscle tone and function to combat its development.

1. Eating a well-balanced, high-protein diet promotes muscle health.

Protein is the building block of muscles. A lack of protein either from insufficient protein intake, increased protein breakdown, or decreased protein production can collectively exacerbate muscle loss. It is recommended that elderly, sarcopenic individuals consume about 1–1.5 g/kg of plant or fish-based protein daily to help reverse muscle loss and to maintain muscle mass.1–3

Additionally, scientific evidence supports that certain supplements are beneficial for muscle. For example, omega-3 fatty acids help reduce and resolve inflammation, which is important for both the prevention and treatment of muscle loss.4 Omega-3 supplements have been shown to improve muscle composition in cancer patients, highlighting the potential benefits in reversing age-related muscle loss.5 According to meta-analyses of three randomized control trials with over 600 sarcopenic patients, whey protein, leucine, and vitamin D improved muscle mass, grip strength, and physical function.6 There is also data to suggest that vitamin D and creatinine supplements can help manage sarcopenia.7

Another important consideration for muscle is proper hydration. According to the Korea and National Health and Nutritional Examination Survey, dehydration was a risk factor for developing sarcopenia.8 Therefore, adequate protein intake, vitamin supplementation, and hydration are important nutritional considerations for maximizing muscle health.

 

2. Participating in frequent resistance exercise promotes muscle health.

Resistance exercise, also known as strength training, is the recommended approach to increasing muscle mass, strength, and power output with age.9 Resistance exercises reinforce muscle contraction using weights, machines, resistance bands, or body weight, which can be easily incorporated into daily routines to significantly improve muscle index, grip strength, and gait speed in older patients.10 Studies show that within three months of consistent resistance exercise, there is a decline in the individual’s sarcopenia-related index.In combination with resistance training, aerobics and balance exercises also improve the physical function and quality of life in sarcopenic patients.11

It is challenging to determine a single exercise regime that will produce the best results for everyone. Variability in age, starting fitness level, types of exercise, and consistency all factor into a person’s progress. However, the data from several studies support that about 2.5 hours of moderate to vigorous-intensity exercise weekly is consistent with improved health outcomes.12

Overall, nutritional supplementation in combination with exercise can improve both muscle strength and function. Therefore, a balanced diet and sufficient resistance training are likely to yield the greatest muscle benefits.

 

3. Historically, single-target approaches to managing sarcopenia have been unsuccessful

While there are no FDA-approved pharmaceuticals to target muscle decline, at least 19 new drug candidates have been investigated for muscle wasting disease. These include monoclonal antibodies, peptides, or single small molecules that target different aspects of muscle regeneration.13 However, a common feature and limitation of these therapies is that they all involve single targets. Human biology is incredibly complex with thousands of factors influencing numerous cellular pathways, making it challenging to address muscle regeneration and function with a single-target approach. Therefore, there is a need to develop a multi-faceted therapeutic that considers these biological intricacies to maximize efficacy.

Immunis is aiming to address these clinical challenges with a multi-active stem cell-derived therapy. Please refer to the resource titled “The Secretome for Muscle Health and Healthspan” for more information.

Additional Resources

  1. Moore, D. R. & Philp, A. Editorial: Nutritional Strategies to Promote Muscle Mass and Function Across the Health Span. Front. Nutr. 7, 569270 (2020).

  2. Wu, W. et al. Dietary protein requirements of older adults with sarcopenia determined by the indicator amino acid oxidation technology. Front. Nutr. 12, (2025).

  3. Daly, R. M. et al. Screening, Diagnosis and Management of Sarcopenia and Frailty in Hospitalized Older Adults: Recommendations from the Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) Expert Working Group. J. Nutr. Health Aging 26, 637–651 (2022).

  4. Bird, J. K., Troesch, B., Warnke, I. & Calder, P. C. The effect of long chain omega-3 polyunsaturated fatty acids on muscle mass and function in sarcopenia: A scoping systematic review and meta-analysis. Clin. Nutr. ESPEN 46, 73–86 (2021).

  5. Murphy, R. A. et al. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer 117, 1775–1782 (2011).

  6. Chang, M. C. & Choo, Y. J. Effects of Whey Protein, Leucine, and Vitamin D Supplementation in Patients with Sarcopenia: A Systematic Review and Meta-Analysis. Nutrients 15, 521 (2023).

  7. Chung, J. Y., Kim, S.-G., Kim, S. H. & Park, C. H. Sarcopenia: how to determine and manage. Knee Surg. Relat. Res. 37, 12 (2025).

  8. Yoo, J.-I. et al. Relationship between water intake and skeletal muscle mass in elderly Koreans: A nationwide population-based study. Nutr. Burbank Los Angel. Cty. Calif 53, 38–42 (2018).

  9. Cadore, E. L., Pinto, R. S., Bottaro, M. & Izquierdo, M. Strength and Endurance Training Prescription in Healthy and Frail Elderly. Aging Dis. 5, 183–195 (2014).

  10. Assyov, Y. et al. Nutritional Management and Physical Activity in the Treatment of Sarcopenic Obesity: A Review of the Literature. Nutrients 16, 2560 (2024).

  11. Shen, Y. et al. Exercise for sarcopenia in older people: A systematic review and network meta-analysis. J. Cachexia Sarcopenia Muscle 14, 1199–1211 (2023).

  12. U.S. Department of Health and Human Services. Physical Activity Guidelines Advisory Committee Report, Part A: Executive Summary. Nutr. Rev. 67, 114–120 (2009).

  13. Dao, T. et al. Sarcopenia and Muscle Aging: A Brief Overview. Endocrinol. Metab. 35, 716–732 (2020).